Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Gezondheidsfondsen luiden noodklok
jun 2024
jan 2024 | Neuro-vasculair
dec 2023 | Bewegingsstoornissen